Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis?

被引：0
|
作者：
M Shargorodsky
M Boaz
Y Goldberg
Z Matas
D Gavish
A Fux
N Wolfson
机构：
[1] Department of Endocrinology,Department of Epidemiology and Statistics
[2] Wolfson Medical Center,Department of Medicine
[3] The Brunner Institute for Cardiovascular Research,Department of Biochemistry
[4] Wolfson Medical Center,undefined
[5] Holon,undefined
[6] Sackler School of Medicine,undefined
[7] Tel Aviv University,undefined
[8] Wolfson Medical Center,undefined
[9] Holon,undefined
[10] Wolfson Medical Center,undefined
[11] Holon,undefined
[12] Wolfson Medical Center,undefined
[13] Holon,undefined
来源：
International Journal of Obesity | 2009年 / 33卷
关键词：
adiponectin; insulin resistance; subclinical atherosclerosis; intima media thickness; arterial elasticity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：553 / 558
页数：5
相关论文
共 50 条
  • [21] Is serum Interleukin-17 associated with early atherosclerosis in obese patients?
    Tarantino, Giovanni
    Costantini, Susan
    Finelli, Carmine
    Capone, Francesca
    Guerriero, Eliana
    La Sala, Nicolina
    Gioia, Saverio
    Castello, Giuseppe
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [22] CAPILLAROSCOPIC OBSERVATION AS EARLY BIOMARKER OF ATHEROSCLEROSIS IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS
    Opoka-Winiarska, V.
    Korobowicz-Markiewicz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1103 - 1103
  • [23] It Is Too Early to Consider Serum Bilirubin as a Definitive Novel Biomarker for Carotid Atherosclerosis
    Qin, Lu
    Wang, Haoyuan
    Zhou, Wanru
    Wang, Hebo
    ANGIOLOGY, 2024, 75 (10) : 1000 - 1000
  • [24] Subclinical atherosclerosis, physical fitness and adiponectin levels in Italian obese children
    Invitti, C.
    Pasqualinotto, L.
    Di Matteo, S.
    Croci, M.
    Gilardini, L.
    Caffetto, K.
    Alberti, L.
    INTERNATIONAL JOURNAL OF OBESITY, 2006, 30 : S23 - S23
  • [25] Serum adiponectin regulates vascular O2-generation and NO bioavailability in patients with coronary atherosclerosis
    Antoniades, C.
    Shirodaria, C.
    Leeson, P.
    Bakogiannis, C.
    Demosthenous, M.
    Antonopoulos, A.
    Tousoulis, D.
    Miliou, A.
    Stefanadis, C.
    Channon, K. M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 11 - 11
  • [26] ATHEROSCLEROSIS IN OBESE PATIENTS AT AUTOPSY
    ROBERTS, JC
    WILKINS, RH
    CIRCULATION, 1958, 18 (03) : 495 - 495
  • [27] Novel methodologies for biomarker discovery in atherosclerosis
    Hoefer, Imo E.
    Steffens, Sabine
    Ala-Korpela, Mika
    Baeck, Magnus
    Badimon, Lina
    Bochaton-Piallat, Marie-Luce
    Boulanger, Chantal M.
    Caligiuri, Giuseppina
    Dimmeler, Stefanie
    Egido, Jesus
    Evans, Paul C.
    Guzik, Tomasz
    Kwak, Brenda R.
    Landmesser, Ulf
    Mayr, Manuel
    Monaco, Claudia
    Pasterkamp, Gerard
    Tunon, Jose
    Weber, Christian
    EUROPEAN HEART JOURNAL, 2015, 36 (39) : 2635 - +
  • [28] Novel biomarker for pulmonary vascular disease in systemic sclerosis patients
    Favoino, E.
    Catacchio, G.
    Mininni, A.
    Ruscitti, P.
    Riccieri, V.
    Liakouli, V.
    Corrado, A.
    Navarini, L.
    Ciccia, F.
    Cipriani, P.
    Cantatore, F. P.
    Valesini, G.
    Giacomelli, R.
    Perosa, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (10) : 1956 - 1963
  • [29] The effects of adiponectin and inflammatory cytokines on diabetic vascular complications in obese and non-obese patients with type 2 diabetes mellitus
    Hong, Seong Bin
    Lee, Jung Jin
    Kim, So Hun
    Suh, Young Ju
    Han, Ju Young
    Kim, Yong Seong
    Nam, Moonsuk
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 111 : 58 - 65
  • [30] Can Adiponectin be a Novel Metabolic Biomarker for Heart Failure?
    Okamoto, Hiroshi
    CIRCULATION JOURNAL, 2009, 73 (06) : 1012 - 1013
12345